Minimally modified low-density lipoprotein induces monocyte adhesion to endothelial connecting segment-1 by activating β1 integrin

Journal of Clinical Investigation

Volumn 103, Issue 5, 1999, Pages 613-625

  Shih, Peggy T ^a   Elices, Mariano J ^b   Fang, Zhuang T ^a   Ugarova, Tatiana P ^c   Strahl, Dana ^b   Territo, Mary C ^a   Frank, Joy S ^a   Kovach, Nicholas L ^d   Cabanas, Carlos ^e   Berliner, Judith A ^a   Vora, Devendra K ^a,f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CYTEL CORPORATION   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

^e UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; FIBRONECTIN; INTEGRIN; LOW DENSITY LIPOPROTEIN;

ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CELL INTERACTION; ENDOTHELIUM CELL; LEUKOCYTE ADHERENCE; LIGAND BINDING; MOLECULAR INTERACTION; MONOCYTE; PRIORITY JOURNAL;

EID: 0033104713     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI5710     Document Type: Article

References (83)

1. Morton, R.E., West, G.A., and Hoff, H.F. 1986. A low density lipoprotein sized particle isolated from human atherosclerotic lesions is internalized by macrophages via a non-scavenger-receptor mechanism. J. Lipid. Res. 27:1124-1134.
2. Hoff, H.F., and Gaubatz, J.W. 1982. Isolation, purification, and characterization of a lipoprotein containing Apo B from the human aorta. Atherosclerosis. 42:273-297.
3. Yla-Herttuala, S., et al. 1989. Evidence for rhe presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J. Clin Invest. 84:1086-1095.
4. Palinski, W., et al. 1989. Low density lipoprotein undergoes oxidative modification in vivo. Proc. Natl. Acad. Sci. USA. 86:1372-1376.
5. Carew, T.E., Schwenke, D.C., and Steinberg, D. 1987. Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit. Proc. Natl. Acad. Sci USA. 84:7725-7729.
6. Kita, T., et al. 1987. Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia. Proc. Natl. Acad. Sci. USA. 84:5928-5931.
7. Gerrity, R.G. 1981. The role of the monocytein atherogenesis. I. Transition of blood-borne monocytes into foam cells in fatty lesions. Am. J. Pathol. 103:181-190.
8. Ross, R. 1995. Cell biology of atherosclerosis. Annu. Rev. Physiol. 57:791-804.
9. Gu, L., et al. 1998. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis low density lipoprotein receptor-deficient mice. Mol. Cell. 2:275-281.
10. Boring, L., Gosling, J., Cleary, M., and Charo, I.F. 1998. Decreased lesion formation in CCR2-/-mice reveals a role for chemokines in the initiation of atherosclerosis. Nature. 394:894-897.
11. Berliner, J.A., et al. 1990. Minimally modified low density lipoprotein stimulates monocyte endothelial interactions. J. Clin. Invest. 85:1260-1266.
12. Watson, A.D., et al. 1997. Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo. J. Biol. Chem. 272:13597-13607.
13. Springer, T.A. 1995. Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration. Annu. Rev. Physiol. 57:827-872.
14. Butcher, E.C. 1991. Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. Cell. 67:1033-1036.
15. Mayadas, T.N., Johnson, R.C., Rayburn, H., Hynes, R.O., and Wagner, D.D. 1993. Leukocyte rolling and extravasation are severely compromised in P selectin-deficient mice. Cell. 74:541-54.
16. Johnson, R.C. et al. 1997. Absence of P-selectin delays fatty streak formation in mice. J. Clin. Invest. 99:1037-1043.
17. Johnson-Tidey, R.R., McGregor, J.L., Taylor, P.R., and Poston, R.N. 1994. Increase in the adhesion molecule P-selectin in endothelium overlying atherosclerotic plaques. Coexpression with intercellular adhesion molecule-1. Am. J Pathol. 144:952-961.
18. Vora, D.K., et al. 1997. Induction of P-selectin by oxidized lipoproteins. Separate effects on synthesis and surface expression. Circ. Res. 80:810-818.
19. Parhami, F., et al. 1993. Minimally modified low density lipoprotein-induced inflammatory responses in endothelial cells are mediated by cyclic adenosine monophosphate. J. Clin. Invest. 92:471-478.
20. Gebuhrer, V., Murphy, J.F., Bordet J.C., Reck, M.P., and McGregor, J.L. 1995. Oxidized low-density lipoprotein induces the expression of P-selectin (GMP140/PADGEM/CD62) on human endothelial cells. Biochem. J. 306:293-298.
21. Yla-Herttuala, S., et al. 1991. Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. Proc. Natl. Acad. Sci. USA. 88:5252-5256.
22. Clinton, S.K., et al. 1992. Macrophage colony-stimulating factor gene expression in vascular cells and in experimental and human atherosclerosis. Am. J. Pathol. 140:301-316.
23. Boisvert, W.A., Santiago, R., Curtiss, L.K., and Terkeltaub, R.A 1998. A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice. J. Clin. Invest. 101:353-363.
24. Cushing, S.D., et al. 1990. Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Proc. Natl. Acad. Sci. USA. 87:5134-5138.
25. Schwartz, D., et al. 1994. Role of the GRO family of chemokines in monocyte adhesion ro MM-LDL-stimulated endothelium. J. Clin. Invest. 94:1968-1973.
26. Rajavashisth, T.B., et al. 1990. Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins. Nature. 344:254-257.
27. Haas, T.A., and Plow, E.F. 1994. Integrin-ligand interactions: a year in review. Curr. Opin. Cell Biol. 6:656-662.
28. Hynes, R.O. 1992. Integrins: versatility, modulation, and signaling in cell adhesion. Cell. 69:11-25.
29. Chan, B.M., Elices, M.J., Murphy, E., and Hemler, M.E. 1992. Adhesion to vascular cell adhesion molecule 1 and fibronectin. Comparison of alpha 4 beta 1 (VLA-4) and alpha 4 beta 7 on the human B cell line JY. J. Biol. Chem. 267:8366-8370.
30. Elices, M. J., et al. 1990. VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site. Cell. 60:577-584.
31. Osborn, L., et al. 1989. Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes. Cell. 59:1203-1211.
32. Qiao, J.H., et al. 1994. Pathology of atheromatous lesions in inbred and genetically engineered mice. Genetic determination of arterial calcification. Arterioscler. Thromb. 14:1480-1497.
33. Cybulsky, M.I., and Gimbrone, M.A., Jr. 1991. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science. 251:788-791.
34. O'Brien, K.D., et al. 1993. Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques. Implications for the mode of progression of advanced coronary atherosclerosis. J. Clin. Invert. 92:945-51.
35. Li, H., Cybulsky, M.I., Gimbrone, M.A., Jr., and Libby, P. 1993. An atherogenic diet rapidly induces VCAM-1, a cytokine-regulatable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium. Arterioscler. Thromb. 13:197-204.
36. Duplaa, C., et al. 1996. Monocyte/macrophage recruitment and expression of endothelial adhesion proteins in human atherosclerotic lesions. Atherosclerosis. 121:253-266.
37. Kim, J.A., et al. 1994. Partial characterization of leukocyte binding molecules on endothelial cells induced by minimally oxidized LDL. Arterioscler. Thromb. 14:427-433.
38. Guan, J.L., and Hynes, R.O. 1990. Lymphoid cells recognize an alternatively spliced segment of fibtonectin via the integrin receptor alpha 4 beta 1. Cell. 60:53-61.
39. Wayner, E.A., Garcia-Pardo, M.J., Humphries, A., McDonald, J.A., and Carter, W.G. 1989. Identification and characterization of the T lymphocyte adhesion receptor for an alternative cell attachment domain (CS-1) in plasma fibronectin. J. Cell. Biol. 109:1321-1330.
40. Humphries, M.J., Komoriya, A., Akiyama, S.K., Olden, K., and Yamada, K.M. 1987. Identification of two distinct regions of the type III connecting segment of human plasma fibronectin that promote cell type-specific adhesion. J. Biol. Chem. 262:6886-6892.
41. Lobb, R.R., and Hemler, M.E. 1994. The pathophysiologic role of alpha 4 integrins in vivo. J. Clin. Invest. 94:1722-1728.
42. Mould, A.P., et al. 1994. Integrin alpha 4 beta 1-mediated melanoma cell adhesion and migration on vascular cell adhesion molecule-1 (VCAM-1) and the alternatively spliced IIICS region of fibronectin. J. Biol. Chem. 269:27224-27230.
43. Mosher, D.F. 1989. Fibronectm. Academic Press Publishers. San Diego, CA. 474 pp.
44. Hynes, R.O. 1990. Fibronectins. Springer-Verlag. New York, NY. 576 pp.
45. Akiyama, S.K., Yamada, S.S., Chen, W.T., and Yamada, K.M. 1989. Analysis of fibronectin receptor function with monoclonal antibodies: roles in cell adhesion, migration, matrix assembly, and cycoskeletal organization. J. Cell. Biol. 109:863-875.
46. Schwarzbauer, J. 1989. Selective secretion of alternatively spliced fibronectm variants. J. Cell. Biol. 109:3445-3453.
47. Elices, M.J., et al. 1994. Expression and functional significance of alternatively spliced CS1 fibronectin in rheumatoid arthritis microvasculature. J. Clin. Invest. 93:405-416.
48. Molossi, S., et al. 1995. Blockade of very late antigen-4 integrin binding to fibronectin with connecting segment-1 peptide reduces accelerated coronary arteriopathy in rabbit cardiac allografts. J. Clin. Invest. 95:2601-2610.
49. Ugarova, T.P., Ljubimov, A.V., Deng, L., and Plow, E.F. 1996. Proteolysis regulates exposure of the IIICS-1 adhesive sequence in plasma fibronectin. Biochemistry. 35:10913-10921.
50. Ljubimov, A.V., et al. 1995. Human corneal basement membrane heterogeneity: topographical differences in the expression of type IV collagen and laminin isoforms. Lab. Invest. 72:461-473.
51. Fogelman, A.M., et al. 1988. Modification of the Recalde method for the isolation of human monocytes. J. Lipid. Res. 29:1243-1247.
52. Wayner, E.A., and Kovach, N.L. 1992. Activation-dependent recognition by hematopoietic cells of the LDV sequence in the V region of fibronectin. J. Cell. Biol. 116:489-497.
53. Lazarovits, A.I., and Karsh, J. 1993. Differential expression in rheumatoid synovium and synovial fluid of alpha 4 beta 7 integrin. A novel receptor for fibronectin and vascular cell adhesion molecule-1. J. Immunol. 151:6482-6489.
54. Kovach, N. L., Carlos, T.M., Yee, E., and Harlan, J.M. 1992. A monoclonal antibody to beta 1 integrin (CD29) stimulates VLA-dependent adherence of leukocytes to human umbilical vein endothelial cells and matrix components. J. Cell Biol. 116:499-509.
55. Luque, A., et al. 1996. Activated conformations of very late activation integrins detected by a group of antibodies (HUTS) specific for a novel regulatory region (355-425) of the common beta 1 chain. J. Biol. Chem. 271:11067-11075.
56. Thoumine, O., Nerem, R.M., and Girard, P.R. 1995. Changes in organization and composition of the extracellular matrix underlying cultured endothelial cells exposed to laminar steady shear stress. Lab. Invest. 73:565-576.
57. van der Laan, LJ., De Groot, C.J., Elices, M.J., and Dijkstra, C.D. 1997. Extracellular matrix proteins expressed by human adult astrocytes in vivo and in vitro: an astrocyte surface protein containing the CS1 domain contributes to binding of lymphoblasts. J. Neurosci. Res. 50:539-48.
58. Wahl, S.M., et al. 1994. Synthetic fibronectin peptides suppress arthritis in rats by interrupting leukocyte adhesion and recruitment. J. Clin. Invest. 94:655-662.
59. Yednock, T.A., et al. 1995. Alpha 4 beta 1 integrin-dependent cell adhesion is regulated by a low affinity receptor pool that is conformationally responsive to ligand. J. Biol. Chem. 270:28740-28750.
60. Pawlowski, N.A., Abraham, E.L., Pontier, S., Scott, W.A., and Cohn, Z.A. 1985. Human monocyte-endothelial cell interaction in vitro. Proc. Natl. Acad. Sci. USA. 82:8208-8212.
61. Masumoto, A., and Hemler, M.E. 1993. Multiple activation states of VLA-4. Mechanistic differences between adhesion to CS1/fibronectin and to vascular cell adhesion molecule-1. J. Biol. Cbem. 268:228-234.
62. Weber, C., Alon, R., Moser, B., and Springer, T.A. 1996. Sequential regulation of α4b1 and α5b1 integrin avidity by CC chemokines in monocytes: implications for transendothelial chemotaxis. J. Cell Biol. 134:1063-1073.
63. Peters, J.H., Sporn, L.A., Ginsberg, M.H., and Wagner, D.D. 1990. Human endothelial cells synthesize, process, and secrete fibronectin molecules bearing an alternatively spliced type III homology (ED1). Blood. 75:1801-1808.
64. Ichihara-Tanaka, K., Titani, K., and Sekiguchi, K. 1995. Role of the carboxyl-terminal Fib2 domain in fibronectin matrix assembly. J. Cell Sci. 108:907-915.
65. Wu, C., Keivens, V.M., O'Toole, T.E., McDonald, J.A., and Ginsberg, M.H. 1995. Integrin activation and cytoskeletal interaction are essential for the assembly of a fibronectin matrix. Cell. 83:715-724.
66. Potts, J.R., and Campbell, I.D. 1996. Structure and function of fibronectin modules. Matrix Biol. 15:313-320.
67. Conforti, G., et al. 1992. Human endothelial cells exptess integrin receptors on the luminal aspect of their membrane. Blood. 80:437-446.
68. McDonald, J.A. 1988. Extracellular matrix assembly. Annu. Rev. Cell Biol. 4:183-207.
69. Checovich, W.J., and Mosher, D.F. 1993. Lysophosphatidic acid enhances fibronectin binding to adherent cells. Arterioscler. Thromb. 13:1662-1667.
70. Ishida, T., Peterson, T.E., Kovach, N.L., and Berk, B.C. 1996. MAP kinase activation by flow in endothelial cells. Role of beta 1 integrins and tyrosine kinases. Circ. Res. 79:310-316.
71. Ylanne, J., et al. 1993. Distinct functions of integrin alpha and beta subunit cytoplasmic domains in cell spreading and formation of focal adhesions. J. Cell. Biol. 122:223-233.
72. Sligh, J.E., Jr., et al. 1993. Inflammatory and immune responses are impaired in mice deficient in intercellular adhesion molecule 1. Proc. Natl. Acad. Sci. USA. 90:8529-8533.
73. McEvoy, L.M., et al. 1997. Novel vascular molecule involved in monocyte adhesion to aortic endothelium in models of atherogenesis. J. Exp. Med. 185:2069-2077.
74. Calderon, T.M., Factor, S.M., Hatcher, V.B., Berliner, J.A., and Berman, J.W. 1994. An endothelial cell adhesion protein for monocytes recognized by monoclonal antibody IG9. Expression in vivo in inflamed human vessels and atherosclerotic human and Watanabe rabbit vessels. Lab. Invest. 70:836-849.
75. Nageh, M.F., et al. 1997. Deficiency of inflammatory cell adhesion molecules protects against atherosclerosis in mice. Arterioscler. Thromb. Vasc. Biol. 17:1517-1520.
76. Elices, M.J. 1995. The integrin alpha 4 beta 1 (VLA-4) as a therapeutic target. Ciba Found. Symp. 189:79-85.
77. Laffon, A., et al. 1991. Upregulated expression and function of VLA-4 fibronectin receptors on human activated T cells in rheumatoid arthritis. J. Clin. Invest. 88:546-552.
78. Rabb, H., Rosen, R., and Ramirez, G. 1995. VLA-4 and its ligands: relevance to kidney diseases. Springer Semin. Immunopathol. 16:417-425.
79. Tamaki, K., et al. 1994. TGF-beta 1 in glomerulosclerosis and interstitial fibrosis of adriamycin nephropathy. Kidney Int. 45:525-536.
80. Sharma, K., and Ziyadeh, F.N. 1994. The emerging role of transforming growth factor-beta in kidney diseases [editorial]. Am. J. Physiol. 266:F829-F842.
81. Palinski, W., et al. 1996. Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein I: deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma. J. Clin. Invest. 98:800-814.
82. Horkko, S., et al. 1996. Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids: recognition of cardiolipin by monoclonal antibodies to epitopes to oxidized low density lipoprotein. J. Clin. Invest. 98:815-825.
83. Fichorova, R., Nakov, L., Baleva, M., Nikolov, K., and Gegova, I. 1996. Sperm, nuclear, phospholipid, and red blood cell antibodies and isotype RF in infertile couples and patients with autoimmune rheumatic diseases. Am. J. Reprod. Immunol. 36:309-316.